Billionaire Profile
David C. Paul
Global Rank
#1746

Image: Unsplash Contributor | Unsplash License | via Unsplash

David C. Paul

CEO, Medical devices
UNITED STATES
Real-Time Net Worth
$2.415B
Estimated based on Medical devices stock value as of April 20, 2026
+0.47% (24h)
Age
59
Source
Medical devices
Industry
healthcare
Citizenship
UNITED STATES

Biography

David C. Paul (born 1966 or 1967) is an American billionaire businessman and the founder and executive chairman of Globus Medical, a medical device manufacturer. Paul's career began in engineering, earning degrees from the University of Madras and Temple University. He worked as an engineer at Synthes before founding Globus Medical in 2003. As of March 2026, his net worth is estimated at $1.4 billion, placing him among the world's wealthiest individuals. His success stems from innovation in spinal surgery, with Globus Medical producing the Excelsius GPS robotic system. Paul's leadership has propelled the company to become a leader in the medical device industry.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

David C. Paul was born in India around 1966 or 1967. He pursued a strong academic foundation in engineering, earning a Bachelor of Science in mechanical engineering from the University of Madras. He later moved to the United States to further his education, obtaining a Master of Science in Computer Integrated Mechanical Engineering Systems from Temple University. This educational background equipped him with a solid understanding of technology and engineering principles, laying the groundwork for his future entrepreneurial endeavors.

Rise to Success

Paul's career began with a role at Synthes, a Swiss medical device company. In 2003, he decided to leverage his engineering expertise and entrepreneurial spirit to found Globus Medical. Globus Medical quickly became a leading innovator in spinal surgery, developing advanced medical devices and technologies. Under Paul's leadership, Globus Medical went public in 2012, marking a significant milestone in the company's growth. In 2017 Paul stepped down as CEO but maintains an active role in the company as executive chairman of the board.

Key Business Strategies

A core strategy of Paul's success has been his focus on innovation, particularly in robotics. Globus Medical's Excelsius GPS robot is a prime example of this. This device helps surgeons perform spinal fusions with greater precision and efficiency. He has also emphasized the importance of understanding doctors' needs to design and create new and superior solutions. Furthermore, maintaining a controlling share of the company has been a key strategic decision, allowing Paul to guide the company's long-term vision and direction. Globus Medical's focus on technological advancements and its commitment to better patient outcomes has been essential to its success.

Philanthropy

While specific details about David Paul's philanthropic initiatives are not widely publicized, it's known that he has made contributions to the University of Miami and Barry University. He has also served in leadership roles at Jackson Memorial Hospital.

Career Milestones

2003

Founded Globus Medical

David Paul established Globus Medical, a medical device company specializing in spinal implants and surgical robotics.

2012

Globus Medical IPO

Took Globus Medical public, a significant step in the company's growth and market presence.

2017

Stepped down as CEO

Transitioned from CEO to Executive Chairman of Globus Medical.

Philanthropy & Social Impact

Education

University of Miami

$0.5B

Donated to the University of Miami.

Education

Barry University

$0.1B

Donated to Barry University.

Business Philosophy & Leadership

Notable Quotes

""This is going to change everything." - On seeing a robot prototype that would change spinal surgery"

Leadership Principles

Innovation

Focusing on the development of new and advanced solutions in the medical device sector.

Understanding doctors' needs

Identifying and addressing the core challenges faced by surgeons to create effective solutions.

Long-Term Vision

Maintaining a controlling share of the company to ensure long-term strategic direction and vision.

Controversies & Challenges

2004

Lawsuit with Synthes

Synthes filed a suit accusing Paul and Globus Medical of poaching workers and misappropriating trade secrets, which was settled in 2007 with Globus paying $13.5 million.